Secondary Logo

Institutional members access full text with Ovid®

Duodenal chemosensitivity and mechanosensitivity in humans during acid and ethanol perfusion

Führer, Martina; Hammer, Johann

European Journal of Gastroenterology & Hepatology: June 2008 - Volume 20 - Issue 6 - p 537-544
doi: 10.1097/MEG.0b013e3282f4e895
Original Articles: Upper Gastrointestinal Tract

Introduction Chemical stimulation with capsaicin in the intestinal lumen induces abdominal pain, presumably through a mechanism involving the polymodal vanilloid receptor TRPV1 (transient receptor potential vanilloid receptor subtype 1). Other stimulators of TRPV1 include heat, acid or ethanol. We evaluated the effects of duodenal acid and ethanol exposure on chemosensitivity and mechanosensitivity in healthy volunteers.

Methods In two placebo-controlled arms of the study, healthy volunteers received duodenal infusions of either hydrochloric acid (0.1 mol/l) (n=8) or ethanol (5% vol/vol) through an oroduodenal tube. Mechanosensitivity was tested applying pressure-controlled duodenal distensions and chemosensitivity was tested by duodenal perfusion with capsaicin (40 μg/ml; 2.5 ml/min). Quality and intensity of upper abdominal symptoms were evaluated with a graded questionnaire during mechanical and chemical stimulation of the duodenum.

Results During hydrochloric acid infusion, capsaicin-induced perception was reduced (P<0.01) and latency to discomfort was increased from 24.5 min (25th/75th%:16.5/36 min) during placebo to 50 min (25.5/60 min) (P<0.01). Ethanol had no significant effect on chemosensitivity [latency to discomfort for placebo vs. ethanol: 26 min (18/40 min) vs. 20 min (9/60 min)] (P>0.05). Neither duodenal acidification nor ethanol altered mechanosensitivity significantly (P>0.05).

Conclusion Duodenal acid activated mechanisms that lead to a decreased sensitivity for intraluminal capsaicin; these mechanisms might protect duodenal chemonociceptors from being sensitized by acid. Whether this mechanism is impaired in patients with upper gastrointestinal functional disease remains to be determined.

Department of Gastroenterology and Hepatology, Medical University of Vienna, Austria

Correspondence to Dr Johann Hammer, Universitätsklinik für Innere Medizin 3, Abteilung für Gastroenterologie und Hepatologie, Währinger Gürtel 18–20, Vienna A-1090, Austria

Tel: +43 1 40400 4741; fax: +43 1 40400 4735;


Received 20 September 2007 Accepted 27 November 2007

© 2008 Lippincott Williams & Wilkins, Inc.